Key Data Highlighting Vidofludimus Calcium's Therapeutic Potential in Multiple Sclerosis Presented at 41st Congress of ECTRIMS  – – Phase 2 CALLIPER ...
NEW YORK, November 13, 2025 – Immunic, Inc. ( Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today ...
Odyssey Math Tuition launches a Secondary 2 online math tuition elearning course in Singapore, featuring a proprietary ...